chrisvoncsefalvay/vaers-outcomes huggingface dataset:
was due for the 2nd dose on 27Apr2021; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTRATION INTERRUPTED (was due for the 2nd dose on 27Apr2021) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Drug hypersensitivity (Allergic to Thimerosal), Drug hypersensitivity (Allergic to Neosporin), Drug hypersensitivity (Allergic to Bacitracin.), Drug hypersensitivity (Allergic to Neomycin) and Allergy (Allergic to things used in Lubricants and Shampoos.).    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTRATION INTERRUPTED (was due for the 2nd dose on 27Apr2021). At the time of the report, PRODUCT ADMINISTRATION INTERRUPTED (was due for the 2nd dose on 27Apr2021) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. The patient reported of shringles and bladder infection but wasn't sure if the patient had them or not. The treatment medications included Cephalexin from 28 APR 2021 to 27Apr2021 for Shringles, Vancyclovir 27Apr2021 to 4May2021 for Bladder infection and Prednisone 27Apr2021 to 4May2021   This case was linked to MOD-2021-114310 (Patient Link).
Reported dizziness 10 mins after injection. VSS. After lying on stretcher for additional 10 minutes, dizziness resolved.
Sterile Diluent Lot# T018894, Exp# 03/02/2023 Merck Vaccines was notified. No recommendation for revaccination.
Patient experienced a seizure like activity for about 2 to 3 minutes after receiving 1st dose of pfizer. He was helped to the floor, and left on his right side until the activity subsided for about 4 minutes. Reported lightheadedness, and no pain. Was given a bottle of water and a protein bar. He was helped up to the chair for a minute, then he wanted to go back on the floor. Stayed in that position for about 20 minutes, before he  went back to the chair, and was advised to sit for at least 15 minutes. He left after 35 minutes, and neither lightheadedness no pain was reported.
Patient screamed for 2 hours straight. Couldn't settle down. Seemed very uncomfortable and just was not himself. It was a nightmare!
This study case was received from the investigator on 27 August 2012. A male subject with no reported past medical history had received ACAM2000 (lot number, route, site and date of administration not reported) and an unspecified amount of time later was found to have on 22 February 2011 an elevated central laboratory Troponin level of 0.27 ng/ml and on 24 February 2011 a central laboratory Troponin level of <0.10 ng/ml. The subject had a rapid Troponin I level on 22 February 2011 that was within normal limits (negative). On 24 February 2011, the subject had a normal ECG reading. Also on 24 February 2011, the subject experienced non-serious events of sore throat, fever, drowsiness, and lightheadedness. The subject was given DAYQUIL and NYQUIL. There was no other reported visit. No further information was available at the time of the report. The subject's outcome was not recovered. According to the Investigator, the event of elevated central lab troponin was considered an important event and possibly related. Per the Investigator, this represents a case of potential myopericarditis and was referred to the study's adjudication committee for assessment. List of docs held by sender: medical records.
Pink firm induration measuring 1.5 inches long by 2 inches wide on Left upper outer aspect of arm (SC area).
pt reported that since vax 6OCT97 has had lt arm pain;pain is increased when lifts arm above head;pt did not seek med tx;c/o constant discomfort @ site;bought new mattress, swims, hot pad etc to try to relieve pain;
Immediately after the patient received the vaccination he stated that his arm felt numb. This seemed to concern him greatly although I reassured him that this reaction had been reported to me on other occasions and it was transient. I checked his blood pressure and pulse, both of which were normal, and he waited for about 20 minutes before returning to work where he received the shot. He returned to the pharmacy approximately 15 minutes later and stated that he felt dizzy, nauseous, and had blurry vision. His forehead felt cold and clammy to the touch and he was sweating. I had him sit, and checked his pulse again (still normal). He stated that his chest felt "cold and tired" but he was not having difficulty breathing. After observing him for some minutes I gave him a 50mg dose of Benadryl in case the reaction was allergic in nature. I observed him for at least 15 more minutes were he seemed calm and was able to speak on his cellphone to family so they could come and pick him up. In my opinion he seemed improved by the time he left but I counseled him to seek medical attention if his adverse feeling worsened. The patient was able to walk out of the Walmart without assistance. I called him at home around 5:20 pm and he sounded very sleepy but he had not yet had to seek further medical attention.
Pt recvd vax 2DEC92 & exp severe burning pain upon inject; whole arm hurt & felt heavy throbbing pain; flushed face, rash on chest, congested sinuses & severe h/a; lightheadedness; 1 hr following inject on way to ER exp chest tightness;
Reporting pt received 2 doses of boostrix in less than the 10 year recommended schedule. pt got one 7/23/2019 and another dose 7/7/22 report vaccine error no adverse reaction noted
Warm; Sweats; weakness; Dizziness,Dizzy,Extremely dizzy; Both the eye lids swollen; Shaking; Fever 101 degree temperature,High fever; Tired; General headache not like migraine,Head ache; Chills; Extreme nausea; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Warm), HYPERHIDROSIS (Sweats), ASTHENIA (weakness), DIZZINESS (Dizziness,Dizzy,Extremely dizzy) and SWELLING OF EYELID (Both the eye lids swollen) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Deep vein thrombosis leg (had acute deep vein thrombosis or DVT in legs which caused pulmonary embolism in lungs,). Concurrent medical conditions included Thyroid disorder, Shellfish allergy, Penicillin allergy and pulmonary embolism in lungs, (had acute deep vein thrombosis or DVT in legs which caused pulmonary embolism in lungs,).    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced FEELING HOT (Warm), HYPERHIDROSIS (Sweats), ASTHENIA (weakness), DIZZINESS (Dizziness,Dizzy,Extremely dizzy), SWELLING OF EYELID (Both the eye lids swollen), TREMOR (Shaking), PYREXIA (Fever 101 degree temperature,High fever), FATIGUE (Tired), HEADACHE (General headache not like migraine,Head ache), CHILLS (Chills), NAUSEA (Extreme nausea) and VOMITING (Vomiting). At the time of the report, FEELING HOT (Warm), HYPERHIDROSIS (Sweats), ASTHENIA (weakness), DIZZINESS (Dizziness,Dizzy,Extremely dizzy), SWELLING OF EYELID (Both the eye lids swollen), TREMOR (Shaking), PYREXIA (Fever 101 degree temperature,High fever), FATIGUE (Tired), HEADACHE (General headache not like migraine,Head ache), CHILLS (Chills), NAUSEA (Extreme nausea) and VOMITING (Vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included thyroid and blood thinner medications. Treatment Medications were not provided by the reporter.
Same day of vaccine on 1/21/2021 later on that day i started to  have arm soreness. The next day on 1/22/2021 I woke up with body aches, chills, nauseous, headache, &  malice I didn't feel good at all. All this symptoms lasted for about 24hrs by the next day 1/23/2021 I was feelin fine I just had arm soreness but by the 1/24/2021 it was gone .
Vertigo; A spontaneous report was received from a  consumer concerning a unknown  patient, , who was administered Moderna's COVID-19 vaccine (mRNA-1273) and experienced vertigo.  The patient's medical history and concomitant history was not provided by the reporter , no lab data was reported .   the patient received their first of two planned doses of mRNA-1273 (Lot number: unknown) intramuscularly in left arm for prophylaxis of COVID-19 infection.  the patient experienced vertigo . the outcome of the events was unknown.   The treatment history was not provided.  The Action taken with the first dose of mRNA-1273 in response to the event was not reported.  The  outcome of the events were considered as unknown.; Sender's Comments:  MOD21-044089:Crosslinked MOD21-044117:Crosslinked
Information has been received from a nurse practioner concerning her 20 year old daughter who on an unspecified date was vaccinated with 0.5 mL of HPV rL1 6111618 VLP vaccine (yeast). It was reported that "right after she got it", the patient developed severe arm pain (date unknown). The patient sought unspecified medical attention. At the time of this report, the patient was recovering from the event. Additional information has been requested.
Muscle pain in the back; Muscle pain in the legs; second vaccine received on day 47; body ache; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Muscle pain in the back), PAIN IN EXTREMITY (Muscle pain in the legs), INCORRECT DOSE ADMINISTERED (second vaccine received on day 47) and MYALGIA (body ache) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030A21A and 022M20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 13-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 14-Apr-2021, the patient experienced BACK PAIN (Muscle pain in the back), PAIN IN EXTREMITY (Muscle pain in the legs), INCORRECT DOSE ADMINISTERED (second vaccine received on day 47) and MYALGIA (body ache). At the time of the report, BACK PAIN (Muscle pain in the back), PAIN IN EXTREMITY (Muscle pain in the legs), INCORRECT DOSE ADMINISTERED (second vaccine received on day 47) and MYALGIA (body ache) outcome was unknown.            Patient stated that he takes blood pressure medication but couldn't remember the name. Treatment information was not provided.
Patient described redness around injection site in right arm the day after vaccination which is gone at this point.  Patient developed red raised rash on both arms, trunk, and back of neck.  Rash still present when arriving at pharmacy 6 days after vaccination on 9/22. Patient was treating with hydrocortisone cream, but did not want to take Benadryl or Claritin as she has also had negative reactions to these medications.  Pharmacist recommended seeing a physician if rash does not improve. Patient stated she thinks the rash is getting better. Patient also said she had a sore throat for a few days afterwards but that is improved.
This spontaneous report as received from a physician assistant refers to a 4-year-old patient of unknown gender. The patient's pertinent medical history, concomitant medication and drug reactions or allergies were not reported. On 28-JUN-2018, the patient was vaccinated with a dose of GARDASIL 9 (dose, frequency, route of administration, vaccination site, lot# and expiration date were not reported) for prophylaxis. No adverse effects were reported. Product Quality Complaint (PQC) was not involved.
On May 19, 1999 the pt developed chickenpox with about 10 vesicles, itching and a temp of 100F, The pt also experienced a headache and swollen glands for about a day. The pt's mother reported that he had been exposed to varicella prior to vax.
Eight days post-covid vaccine #1, I developed a hard, raised, red, hot, itchy, lump at the injection site. The rash is circular and about 1.5 inches wide/high. It does not appear to be spreading or getting larger.
Client reported development of shortness of breath, chills, fever,  and nasal congestion 2 days after the 1st COVID vaccine Pfizer. The client stated the symptoms lasted one week. The has a history of asthma and is prescribed Albuterol. The client stated she used her Albuterol inhaler, which helped with the shortness of breath. The client presented to the emergency department for evaluation in order to return to work. The client states she was prescribed Tylenol in the emergency department. The client also received a negative COVID test while in the emergency department. The client has a history of allergies to cats which is controlled with Loratadine.
Severe headache, nausea, vomiting, fever for almost 4 weeks.
Swollen lymph nodes in armpit of injection side. Swelling, heat, tenderness, pain radiating into muscle over breast, cannot put arm down due to axillary pain.
Shortly after the shot: - Dizziness - Weakness  Later: - Sore left arm - Chest pain, left side - Fatigue - Anxiety, perhaps triggered by all of that.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 019B21A and 014M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Mar-2021 at 3:02 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 30-Mar-2021 at 2:53 AM, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. In March 2021, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 44.10 for dose administered on 02-Mar-2021 and 44.17 for dose administered on 30-Mar-2021. No concomitant and treatment medications were reported.  Batch number 014M20A (dose-1) underwent temperature excursion on 02-Mar-2021 with temperature 27,29,32,33,35,36 degrees Fahrenheit from  09:00 AM to 3:00PM. This vial was moved to fridge on 24-Feb-2021 and beyond use date for the vial was reported as 26-Mar-2021. Product moved to clinic on 02-Mar-2021.  Batch number 019B21A (dose-2) underwent temperature excursion on 30-Mar-2021 with temperature 33 degrees Fahrenheit from 09:00 AM. This vial was moved to fridge on 23-Mar-2021 and beyond use date for the vial was reported as 22-Apr-2021. Product moved to clinic on 30-Mar-2021.   Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a traceable temperature monitor at every hour.   This case was linked to MOD-2022-566976 (Patient Link).
I started feeling chills around 6:30PM the day of the vaccine and around 8PM I was uncontrollably shaking, shivering, I could not stop shaking, heating blankets could not help me stop shaking. In the middle of the night I developed fever and nausea (very intense nausea). Temp was 100.8F when I finally decided to take it. Also noticed my heart was racing.  I did take Tylenol. I started with a 500mg pill and it calmed it a little and then took another one 2 hours later and it did not help anything so I decided to switch it to Ibuprofen (600mg) and that helped me much better.  The heart racing felt much better. Woke up and felt like I was recovering from the flu, had body aches and dizzy, I felt like I could fall, fever went away that day and body aches and chills and headache were still present. I started having the arm pain and swelling at the injection site.  I started finally feeling somewhat better on the following Monday. But then the same week some days later I started feeling that I need to cough (with phlegm) some days later. I was better of the other symptoms but then the cough came. Consulted with PCP who decided to have an X Ray and it was done at the hospital l about 1 week after the vaccination.  I am available to be contacted if needed.
two fingers on left arm became stiff and can't move; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (two fingers on left arm became stiff and can't move) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (two fingers on left arm became stiff and can't move). At the time of the report, MUSCULOSKELETAL STIFFNESS (two fingers on left arm became stiff and can't move) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported.  No treatment information was provided.     Reporter did not allow further contact
This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Lightheadedness) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Lightheadedness). At the time of the report, DIZZINESS (Lightheadedness) outcome was unknown. Not Provided          No concomitant medications or treatment details reported.
Patient is a 68 y.o. female who has underlying problems of lung cancer status post left lobectomy, chronic obstructive pulmonary disease, IgG deficiency, and is on chronic corticosteroids.  She became acutely short of breath at around 4:00 a.m. and felt her heart racing and was very weak.  She had a home pulse oximeter which read 88% she came to the emergency room where her heart rate was in the 150+ range in sinus tachycardia, and she had hypoxemia treated with nasal cannula oxygen and then a trial of BiPAP in the emergency department.  Chest x-ray demonstrated multi focal pneumonia.  Labs showed bandemia and lactic acidosis.  She was treated with saline bolusing, cefepime, and IV doxycycline, and Solu-Medrol 125 mg a duo neb.  she was initially placed on nasal cannula oxygen but appeared is persistently tachypneic and was given a trial of BiPAP for on which she is breathing comfortably at present.
Patient received 4th dose of Pediarix; This case was reported by a other health professional via call center representative and described the occurrence of extra dose administered in a 6-month-old female patient who received DTPa-HBV-IPV (Pediarix) (batch number X9HF4, expiry date 25th March 2024) for prophylaxis.   Co-suspect products included dtpa-hbv-ipv vaccine pre-filled syringe device (Pediarix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 1st September 2022, the patient received the 4th dose of Pediarix and Pediarix Pre-Filled Syringe Device. On 1st September 2022, unknown after receiving Pediarix and Pediarix Pre-Filled Syringe Device, the patient experienced extra dose administered. On an unknown date, the outcome of the extra dose administered was unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 01-Sept-2022 Reporter's comment: The reporter consented to follow-up. Additional supportive information: The patient received 4th dose of Pediarix, which led to extra dose administered.
Reports after a vaccine was given to Pt, the next morning she noticed increased sensitivity to her left arm where vaccine was given. Later that day it became hot and rigid. This lasted Sunday and Monday and was still a little red Tuesday but getting better.
Patient received his first maternal vaccination on January 15.  By January 21 he began to complain of double vision.  His wife also noted some slight slurred speech.  He went to the emergency room and was told that he had a 6th nerve palsy on the left.  A scan of his head was unremarkable.  He was referred to neurology.  I saw him on February 2 and by that time he had evidence of full-blown myasthenia gravis with left ptosis, slurred speech, intermittent disconjugate gaze, some subjective difficulty swallowing.. 1 wk laterSevere dysphagia unable to swallow without puréeing food marked slurred speech and ptosis .SENT FOR EMERGENCY IVIG
Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Shakiness-Mild, Systemic: Weakness-Mild
On 10/14/99, the pt received a flu vaccine and a pneumococcal vaccine and 4 - 5 minutes post vax, the pt suffered a bleeding stroke and was sent to the hospital. The pt remained in the hospital for 7 weeks and is still in rehabilitation. The pt was told that he was the fourth pt admitted to the hospital with a stroke after receiving the flu vaccine. There was a recall of three county areas (outdated) while the pt was in the hospital. "Additional information per call to reporter 5/10/2000. At the time of the incident the reporter was 66 years old and in good health. He received a flu vaccine and a pneumococcal vaccine. he contacted the facility where he received to get the manufacturers names and was told that the manufacturers vary; he was given a lot number of 456690, but does not know which product it is for.
This spontaneous report as received from a consumer refers to a male patient of unknown age (the reporter's grandson). In approximately 2013 (also reported as a couple of months ago) the patient was vaccinated with VARIVAX (Merck) (dose, route, lot number, expiration date and indication were not provided). The reporter stated that recently the patient was diagnosed with a mild case of chickenpox (onset date not provided). No symptoms were provided. The patient's outcome was not provided. The relatedness between the event of chickenpox and the vaccination with VARIVAX (Merck) was not reported. Additional information is not expected.